Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe

Contributed by: GlobeNewswire

Tags

AI cancer screening

More Like This

PR Newswire associated0

Volpara Health Surpasses 300 Peer-Reviewed Papers

PR Newswire associated0

ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR

PR Newswire associated0

ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

Volpara to Highlight Growing AI Suite for Mammography at ECR 2024, Including New Lunit Distribution Agreement

PR Newswire associated0

ScreenPoint Medical: AI-Enhanced Mammography Screening Significantly Improves Breast Cancer Detection and Reduces Radiologist Workload

PR Newswire associated0

ScreenPoint Medical Hits New Milestones

PR Newswire associated0

b-rayZ Secures CE Mark for Industry-First Custom AI Technology, Revolutionizing End-to-End Breast Diagnostics

PR Newswire associated0

Transpara Announces New FDA Clearance Designed to Improve Breast Cancer Detection at RSNA